GHOSH ANIRVAN (Chief Executive Officer) sold 1.5% of their position (1.25K shares) of UNITY BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $3.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/15/2023ACC: 0000950170-23-048372
DirectorOfficer· Chief Executive Officer
Since Mar 2020
-1.25K
Net shares
Net seller
$3.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.25K disposed
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
−1.25K
Price / share
$2.47
Trade value
$3.08K
% of position
1.5%
9/14/2023
83.47K→82.22K
Total
Net shares
−1.25K
Net value
-$3.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 9/14/2023 | S · Sale | −1.25K | $2.47 | $3.08K | 1.5% | 83.47K | 82.22K |
| Total | −1.25K | -$3.08K | ||||||
Derivative Transactions0
No derivative transactions reported